Rebecca Mcketin (Rebecca McKetin, Rebecca McKETIN)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 36

Top Topics

Randomized Controlled Trial

Smoking Cessation

Top Venues

Drug and alcohol review

Addiction (Abingdon, England)

Psychological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca Mcketin, Simon Clay
Virtual contingency management, what is it worth and who will pay for it? Addiction (Abingdon, England) (2024)
Rebecca Mcketin, Tayla J Degan, Lucy Saunders, Long Nguyen, Gregory Dore, Steven Shoptaw, Michael Farrell, Louisa Degenhardt, Peter J Kelly, Alyna Turner, Philip J Clare, Olivia M Dean, Shalini Arunogiri, Samantha Colledge-Frisby, Juanita Koeijers, David Goodman-Meza, Barbara Sinclair, David Reid, Harry Hill, Jeremy Hayllar, Michael Christmass, Frank Cordaro, Robert Lundin, Willy Liaw, Danica Liu, Ellie Holyoak, Brian Tid-Fung Wu, Joel Keygan, Ava Kontogiannis, Lily Palmer, Caity Morrison, Anna Wrobel, Bec Hyland, Marianne Byrne, Samantha Russell, Emma Zahra, Michael Berk
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial. Trials 25 (1) (2024)
Rebecca Mcketin, Simon Clay
Virtual contingency management, what is it worth and who will pay for it? Addiction (Abingdon, England) 119 (9) (2024)
Rebecca Mcketin, Tayla J Degan, Lucy Saunders, Long Nguyen, Gregory Dore, Steven Shoptaw, Michael Farrell, Louisa Degenhardt, Peter J Kelly, Alyna Turner, Philip J Clare, Olivia M Dean, Shalini Arunogiri, Samantha Colledge-Frisby, Juanita Koeijers, David Goodman-Meza, Barbara Sinclair, David Reid, Harry Hill, Jeremy Hayllar, Michael Christmass, Frank Cordaro, Robert Lundin, Willy Liaw, Danica Liu, Ellie Holyoak, Brian Tid-Fung Wu, Joel Keygan, Ava Kontogiannis, Lily Palmer, Caity Morrison, Anna Wrobel, Bec Hyland, Marianne Byrne, Samantha Russell, Emma Zahra, Michael Berk
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial. Trials 25 (1) (2024)
Rebecca Mcketin, Tayla J Degan, Lucy Saunders, Long Nguyen, Gregory Dore, Steven Shoptaw, Michael Farrell, Louisa Degenhardt, Peter J Kelly, Alyna Turner, Philip J Clare, Olivia M Dean, Shalini Arunogiri, Samantha Colledge-Frisby, Juanita Koeijers, David Goodman-Meza, Barbara Sinclair, David Reid, Harry Hill, Jeremy Hayllar, Michael Christmass, Frank Cordaro, Robert Lundin, Willy Liaw, Danica Liu, Ellie Holyoak, Brian Tid-Fung Wu, Joel Keygan, Ava Kontogiannis, Lily Palmer, Caity Morrison, Anna Wrobel, Bec Hyland, Marianne Byrne, Samantha Russell, Emma Zahra, Michael Berk
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial. Trials 25 (1) (2024)
Simon Clay, Zachary Wilkinson, Meredith Ginley, Shalini Arunogiri, Michael Christmass, Dean Membrey, Paul MacCartney, Rachel Sutherland, Samantha Colledge-Frisby, Alison D Marshall, Jack Nagle, Louisa Degenhardt, Michael Farrell, Rebecca Mcketin
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia. Drug and alcohol review (2024)
Simon Clay, Zachary Wilkinson, Meredith Ginley, Shalini Arunogiri, Michael Christmass, Dean Membrey, Paul MacCartney, Rachel Sutherland, Samantha Colledge-Frisby, Alison D Marshall, Jack Nagle, Louisa Degenhardt, Michael Farrell, Rebecca Mcketin
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia. Drug and alcohol review 43 (5) (2024)
Rebecca Mcketin, Tayla J Degan, Lucy Saunders, Long Nguyen, Gregory Dore, Steven Shoptaw, Michael Farrell, Louisa Degenhardt, Peter J Kelly, Alyna Turner, Philip J Clare, Olivia M Dean, Shalini Arunogiri, Samantha Colledge-Frisby, Juanita Koeijers, David Goodman-Meza, Barbara Sinclair, David Reid, Harry Hill, Jeremy Hayllar, Michael Christmass, Frank Cordaro, Robert Lundin, Willy Liaw, Danica Liu, Ellie Holyoak, Brian Tid-Fung Wu, Joel Keygan, Ava Kontogiannis, Lily Palmer, Caity Morrison, Anna Wrobel, Bec Hyland, Marianne Byrne, Samantha Russell, Emma Zahra, Michael Berk
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial. Trials 25 (1) (2024)
Craig Cumming, Stuart A Kinner, Rebecca Mcketin, Jesse Tyler Young, Ian Li, David B Preen
The predictive validity of the Alcohol Smoking and Substance Involvement Screening Test (ASSIST) for moderate-to-high risk cannabis, methamphetamine and opioid use after release from prison. Addiction (Abingdon, England) (2023)
Craig Cumming, Stuart A Kinner, Rebecca Mcketin, Jesse Tyler Young, Ian Li, David B Preen
Using the Alcohol, Smoking and Substance Involvement Screening Test to predict substance-related hospitalisation after release from prison: A cohort study. Addiction (Abingdon, England) (2023)
Chrianna Bharat, Paige Webb, Zachary Wilkinson, Rebecca Mcketin, Jason Grebely, Michael Farrell, Adam Holland, Matthew Hickman, Lucy Thi Tran, Brodie Clark, Amy Peacock, Shane Darke, Jih-Heng Li, Louisa Degenhardt
Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis. Addiction (Abingdon, England) (2023)
Craig Cumming, Stuart A Kinner, Rebecca Mcketin, Jesse Tyler Young, Ian Li, David B Preen
The predictive validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for moderate- to high-risk cannabis, methamphetamine and opioid use after release from prison. Addiction (Abingdon, England) (2023)
Craig Cumming, Stuart A Kinner, Rebecca Mcketin, Ian Li, David B Preen
The health needs of people leaving prison with a history of methamphetamine and/or opioid use. Drug and alcohol review (2023)
Janni K Y Leung, Tesfa Mekonen Yimer, XiaoXuan Wang, Shalini Arunogiri, Louisa Degenhardt, Rebecca Mcketin
Methamphetamine exposure and depression-A systematic review and meta-analysis. Drug and alcohol review (2023)
Simon Clay, Zachary Wilkinson, Meredith Ginley, Shalini Arunogiri, Michael Christmass, Dean Membrey, Paul MacCartney, Rachel Sutherland, Samantha Colledge-Frisby, Alison D Marshall, Jack Nagle, Louisa Degenhardt, Michael Farrell, Rebecca Mcketin
Perspectives and sentiments on contingency management from people who use methamphetamine. Drug and alcohol review (2023)
Rebecca Mcketin, Philip James Clare, David Castle, Alyna Turner, Peter J Kelly, Daniel I Lubman, Shalini Arunogiri, Victoria Manning, Michael Berk
How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: evidence from longitudinal panel data. Addiction (Abingdon, England) (2023)
Gregory Leigh Carter, Matthew J Spittal, Linda Glowacki, Dimitri Gerostamoulos, Paul Dietze, Barbara Sinclair, Shalini Arunogiri, Michael Berk, Daniel I Lubman, Victoria Manning, Peter Higgs, Brendan Quinn, Amanda Baker, Olivia M Dean, Alyna Turner, Rebecca Mcketin
Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine-dependent intervention trial population. Addiction (Abingdon, England) (2022)
Liam S Acheson, Benjamin H Williams, Michael Farrell, Rebecca Mcketin, Nadine Ezard, Krista J Siefried
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials. Drug and alcohol review (2022)
Joseph M Boden, James A Foulds, Giles Newton-Howes, Rebecca Mcketin
Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort. Psychological medicine (2021)
Rebecca Mcketin, Rachel Sutherland, Amy Peacock, Michael Farrell, Louisa Degenhardt
Patterns of smoking and injecting methamphetamine and their association with health and social outcomes. Drug and alcohol review 40 (7) (2021)
Rebecca Mcketin
Household surveys and the case of the Australian methamphetamine situation. Addiction (Abingdon, England) 116 (10) (2021)
Rebecca Mcketin, Agata Chrzanowska, Nicola Man, Amy Peacock, Rachel Sutherland, Louisa Degenhardt
Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003-2019. Drug and alcohol review 40 (7) (2021)
Rebecca Mcketin, Michael Farrell
When the evidence is not enough: is it time to rethink trial design? Addiction (Abingdon, England) 116 (4) (2020)
Rebecca Mcketin, Brendan Quinn, Peter Higgs, Michael Berk, Olivia M Dean, Alyna Turner, Peter J Kelly, Dan I Lubman, Gregory Carter, Amanda L Baker, Victoria Manning, Tamsin Thomas, Ramez Bathish, Dayle Raftery, Lucy Saunders, Anna Wrobel, Alcyone Meehan, Barbara Sinclair, David Reid, Shalini Arunogiri, Harry Hill, Frank Cordaro, Paul M Dietze
Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial. Drug and alcohol review 40 (7) (2020)
Brendan Quinn, Bernadette M Ward, Paul A Agius, Rebecca Jenkinson, Matthew Hickman, Keith Sutton, Cristal Hall, Rebecca Mcketin, Michael Farrell, Reece David Cossar, Paul M Dietze
A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence. Drug and alcohol review 40 (7) (2020)
Craig Cumming, Stuart A Kinner, Rebecca Mcketin, Ian Li, David Preen
Methamphetamine use, health and criminal justice system outcomes: A systematic review. Drug and alcohol review 39 (5) (2020)
Rachel Reilly, Handan Wand, Rebecca Mcketin, Brendan Quinn, Nadine Ezard, Adrian Dunlop, Katherine M Conigrave, Carla Treloar, Yvette Roe, Dennis Gray, Jacqueline Stephens, James Ward, null null
Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey. Drug and alcohol review 39 (6) (2020)
Dayle K Raftery, Peter J Kelly, Frank P Deane, Rebecca Mcketin, Amanda L Baker, Alyna Turner, Olivia M Dean
Measuring cognitive insight in people with problematic substance use: An exploration of the factor validity of the Beck Cognitive Insight Scale. Drug and alcohol review 38 (6) (2019)
Rebecca Mcketin
Why methamphetamine-related deaths need more attention. Addiction (Abingdon, England) 112 (12) (2019)
Rebecca Mcketin, Olivia M Dean, Alyna Turner, Peter J Kelly, Brendan Quinn, Dan I Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Amanda L Baker, Barbara Sinclair, David Reid, Victoria Manning, Nina Te Pas, Wenbin Liang, Tamsin Thomas, Ramez Bathish, Margaret Kent, Dayle Raftery, Shalini Arunogiri, Frank Cordaro, Harry Hill, Michael Berk
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence. Trials 20 (1) (2019)
Rebecca Mcketin, Alexandra Voce, Richard Burns, Marian Shanahan
Health-related quality of life among people who use methamphetamine. Drug and alcohol review 38 (5) (2019)
Rachel Reilly, Rebecca Mcketin, Handan Wand, Julia Butt, Matthew F Smout, Nadine Ezard, Katherine M Conigrave, Yvonne Clark, Brendan Quinn, Carla Treloar, Dennis Gray, Melissa A Jackson, Yvette Roe, James Ward
A Web-Based Therapeutic Program (We Can Do This) for Reducing Methamphetamine Use and Increasing Help-Seeking Among Aboriginal and Torres Strait Islander People: Protocol for a Randomized Wait-List Controlled Trial. JMIR research protocols 8 (7) (2019)
Shalini Arunogiri, Rebecca Mcketin
Comment on Zang et al 2019: The importance of distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use. Addiction biology 25 (2) (2019)
Rebecca Mcketin, Daniel I Lubman, Amanda Baker, Sharon Dawe, Joanne Ross, Richard P Mattick, Louisa Degenhardt
The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study. Addiction (Abingdon, England) 113 (7) (2018)
Kerry A Howard, Kathleen Margaret Griffiths, Rebecca Mcketin, Jennifer S Ma
Can a brief biologically-based psychoeducational intervention reduce stigma and increase help-seeking intentions for depression in young people? A randomised controlled trial. Journal of child and adolescent mental health 30 (1) (2018)
Rebecca Mcketin
Methamphetamine psychosis: insights from the past. Addiction (Abingdon, England) 113 (8) (2018)
Robert J Tait, Rebecca Mcketin, Frances J Kay-Lambkin, Bradley Carron-Arthur, Anthony Bennett, Kylie Bennett, Helen Christensen, Kathleen Margaret Griffiths
Six-month outcomes of a Web-based intervention for users of amphetamine-type stimulants: randomized controlled trial. Journal of medical Internet research 17 (4) (2015)
Robert J Tait, Rebecca Mcketin, Frances J Kay-Lambkin, Bradley Carron-Arthur, Anthony Bennett, Kylie Bennett, Helen Christensen, Kathleen Margaret Griffiths
A Web-Based Intervention for Users of Amphetamine-Type Stimulants: 3-Month Outcomes of a Randomized Controlled Trial. JMIR mental health 1 (1) (2014)